Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms
Albert Font, Ramon Salazar, Joan Maurel, Miquel Taron, Jose Luis Ramirez, Josep Tabernero, Rosa Gallego, Esther Casado, Jose Luis Manzano, Enric Carcereny, Marta Guix, Jaume Fernández-Llamazares, RafaVolume:
62
Language:
english
Pages:
9
DOI:
10.1007/s00280-008-0700-3
Date:
November, 2008
File:
PDF, 426 KB
english, 2008